09\/25\/2020 | 09:50am EDT<\/p>\n
BRAIN Group <\/p>\n
Pioneering Bioproducts <\/p>\n
Investor Presentation <\/p>\n
Zwingenberg, September 15th, 2020 <\/p>\n
Pioneering Bioproducts. <\/p>\n
BRAIN Aktiengesellschaft Zwingenberg Germany http:\/\/www.brain-biotech.com<\/a> +49 (0) 6251-9331-0 <\/p>\n 1 <\/p>\n Safe Harbor Statement <\/p>\n This document may contain forward-looking statements. These forward-looking statements are subject to risks and uncertainties, as they relate to future events and are based on current assumptions of the Company, which may not occur at all in the future or may not occur as assumed. They do not represent a guarantee for future results or performance of the Company, and the development of economic and legal conditions may materially differ from the information expressed or implied in the forward-looking statements. <\/p>\n The Company assumes no obligation to update or revise any forward-looking statement contained herein or to adapt them to future events or developments. The information contained in this document has not been independently verified. No representation or warranty expressed or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinion contained herein. The Company or any of its shareholders, affiliates, advisors, employees or representatives shall have no liability whatsoever (in negligence or otherwise) for any loss arising from any use of this document or its content or otherwise arising in connection with this document. <\/p>\n By accepting this presentation you acknowledge that you will be solely responsible for your own assessment of the market and the market position of the Company and that you will conduct your own analysis and be solely responsibility for forming your own view of the potential future performance of the Company's business. <\/p>\n This presentation speaks as of September 15th, 2020. Neither the delivery of this presentation nor any further discussions of the Company with any of the recipients shall, under any circumstances, create any implication that there has been no change in the affairs of the Company since such date. The term \"BRAIN\", as used in this presentation means B.R.A.I.N. Biotechnology Research and Information Network AG and its affiliates, if not otherwise specified. <\/p>\n Pioneering Bioproducts. <\/p>\n BRAIN Aktiengesellschaft Zwingenberg Germany http:\/\/www.brain-biotech.com<\/a> +49 (0) 6251-9331-0 <\/p>\n 2 <\/p>\n Brain at a Glance <\/p>\n ~ 39m <\/p>\n '18\/'19 Revenues <\/p>\n > 27 <\/p>\n Years of Experience <\/p>\n ~ 300 <\/p>\n Employees <\/p>\n > 100 <\/p>\n Specialty B2B Products <\/p>\n > 100 <\/p>\n Industrial Partnerships <\/p>\n 2016 <\/p>\n Listed, Frankfurt Prime Standard <\/p>\n Creating Breakthrough Bioproducts & Solutions for Nutrition, Health and Environment <\/p>\n Industrial Biotech <\/p>\n Three <\/p>\n (white) <\/p>\n Product Platforms <\/p>\n Enzymes <\/p>\n Microorganisms <\/p>\n Bioactive <\/p>\n Natural <\/p>\n Compounds <\/p>\n From the Lab to Production <\/p>\n Pioneering Bioproducts. <\/p>\n BRAIN Aktiengesellschaft Zwingenberg Germany http:\/\/www.brain-biotech.com<\/a> +49 (0) 6251-9331-0 <\/p>\n 3 <\/p>\n Mission & Vision <\/p>\n \"Mission is what an organization is or does. Vision is what an organization desires to become\" <\/p>\n Mission <\/p>\n Creating Breakthrough Bioproducts and Solutions for Nutrition, Health and the Environment <\/p>\n Vision <\/p>\n We will be the Industrial\/White Biotech Specialists in finding and exploring high-value niches in our products business and novel solutions in our Science business. We will be much more agile than others and will always look to produce products in-house or with partners <\/p>\n Pioneering Bioproducts. <\/p>\n BRAIN Aktiengesellschaft Zwingenberg Germany http:\/\/www.brain-biotech.com<\/a> +49 (0) 6251-9331-0 <\/p>\n 4 <\/p>\n This is Brain <\/p>\n Brain AG <\/p>\n BioScienceBioIndustrial <\/p>\n Solutions & Services <\/p>\n Products <\/p>\n Breakthroughs <\/p>\n Stable Service Business with Upside <\/p>\n Innovation & Optimization <\/p>\n Own and Partnered NBD TMS BioActive Compound Libraries Enzymes Microorganisms Bioactives <\/p>\n ~ 5m-7m Annual <\/p>\n ~ 12m Annual Revenues* <\/p>\n ~ 26m Annual Revenues <\/p>\n Cost-plus Contract research, <\/p>\n Investment <\/p>\n >10% EBITDA Margin* <\/p>\n Milestones, Technology & License Fees <\/p>\n *FY '18\/'19 <\/p>\n Pioneering Bioproducts. <\/p>\n BRAIN Aktiengesellschaft Zwingenberg Germany http:\/\/www.brain-biotech.com<\/a> +49 (0) 6251-9331-0 <\/p>\n 5 <\/p>\n Why Invest in BRAIN <\/p>\n Multiple Triggers for strong Revenue and Margin Growth <\/p>\n Pioneering Bioproducts. <\/p>\n BRAIN Aktiengesellschaft Zwingenberg Germany http:\/\/www.brain-biotech.com<\/a> +49 (0) 6251-9331-0 <\/p>\n 6 <\/p>\n BRAIN: At the Heart of UN Sustainable Development Goals <\/p>\n Our Products and Solutions address at least six Goals directly <\/p>\n Sugar Replacement <\/p>\n Sugar Taste Enhancer <\/p>\n Salt Replacement <\/p>\n Salt Taste Enhancer <\/p>\n Natural Aromas <\/p>\n Anti-Microbials Wound Treatment <\/p>\n Natural Preservatives Bioactive Plant Cosmetics <\/p>\n Green Mining <\/p>\n Phosphate Recycling <\/p>\n Green Mining Microbial CO2 Usage <\/p>\n Biological Production <\/p>\n Urban Mining <\/p>\n Improving Production Efficiencies <\/p>\n Fermented Food from Sidestreams <\/p>\n Pioneering Bioproducts. <\/p>\n BRAIN Aktiengesellschaft Zwingenberg Germany <\/p>\n http:\/\/www.brain-biotech.com<\/a> +49 (0) 6251-9331-0 <\/p>\n 7 <\/p>\n Our Targets <\/p>\n This FY <\/p>\n <\/p>\n Read the original: 09\/25\/2020 | 09:50am EDT BRAIN Group Pioneering Bioproducts Investor Presentation Zwingenberg, September 15th, 2020 Pioneering Bioproducts. BRAIN Aktiengesellschaft Zwingenberg Germany http:\/\/www.brain-biotech.com<\/a> +49 (0) 6251-9331-0 1 Safe Harbor Statement This document may contain forward-looking statements Continue reading
\nBRAIN Biotechnology Research and Information Network : BRAIN - Investor Presentation - Marketscreener.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"